Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
An extension study to evaluate the safety and efficacy of an anti-CD19 CAR-T product in patients with B-cell lymphoproliferative disorders, …
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia [Phase 4]
Phase 4 clinical trial updating on the minimum effective concentration and volume of ropivacaine for sacral plexus anesthesia in pediatric p…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort
The QUALITY cohort study (Quebec Adipose and Lifestyle Investigation in Youth) is active but not recruiting, examining obesity, Type 2 diabe…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Comparison of Computertomography Scan, Electrical Impedance Tomography, and Ultrasound of the Lung in Infants
A clinical trial comparing computed tomography, electrical impedance tomography, and ultrasound for assessing lung status in infants is curr…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic Leukemia
This clinical trial update describes a study evaluating the systemic inflammation response index and the C-reactive protein to albumin ratio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease. [EARLY_Phase 1]
An early-phase trial evaluating the safety and efficacy of PRG-2302 for refractory or relapsed B-cell acute lymphoblastic leukemia, currentl…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Effectiveness of Developed Interactive Play Mat In Pediatric Physical Therapy [NA]
This document reports on an ongoing clinical trial evaluating the effectiveness of an interactive play mat in pediatric physical therapy for…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse [Phase 2]
Phase 2 study evaluating ponatinib in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia, including MRD-positive and …
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study
A multicenter study is evaluating reduced-dose chemotherapy followed by 14 days of blinatumomab for newly diagnosed adult B-lymphoblastic le…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL [Phase 1]
Phase 1 clinical trial evaluating CD19-targeted CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia.
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL [Phase 1, Phase 2]
A Phase 1/2 trial evaluating anti-CD19 CAR-NK cell therapy in relapsed or resistant acute lymphoblastic leukemia. The study is currently not…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention [NA]
The study uses integrative 'omics' approaches to identify leukemia targets and matched therapeutic interventions and is currently recruiting…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial investigating autologous hematopoietic stem cell transplantation combined with CD19-CAR T-cell therapy for adult high…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms [Phase 1]
Phase 1 trial of CD19-targeted CAR T cells for refractory/relapsed CD19-positive B-cell neoplasms (ALL, mantle cell lymphoma, diffuse large …
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia [EARLY_Phase 1]
A clinical trial is investigating whether levocarnitine can reduce asparaginase-associated hepatotoxicity in patients with acute lymphoblast…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients [NA]
ClinicalTrials.gov update describes a study evaluating laser therapy to reduce oral mucositis in children with acute lymphoblastic leukemia.…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma
A clinical trial update evaluating glucose intolerance and diabetes related to steroid and PEG-asparaginase treatment in children and adoles…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Vitamin A and D Supplementation in Allogeneic HCT [Phase 2]
Phase 2 clinical trial in allogeneic hematopoietic cell transplantation is evaluating vitamin A and vitamin D supplementation, currently rec…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Update on cytogenetic studies in acute leukemia and multiple myeloma; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia [Phase 2]
A Phase II clinical trial is evaluating low-dose inotuzumab ozogamicin after transplant to prevent relapse in patients with acute lymphoblas…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR [Phase 1, Phase 2]
A Phase 1/2 clinical trial at University Hospital Heidelberg is evaluating third-generation CD19-directed CAR T cells in relapsed or refract…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: the Efficacy and Safety of Total Myeloid Irradiation (TMI) in the Treatment of Adult Acute Lymphoblastic Leukemia
An update on a clinical trial evaluating the efficacy and safety of Total Myeloid Irradiation for adults with acute lymphoblastic leukemia, …
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021) [Phase 3]
Phase 3 clinical trial evaluating combined immunotherapy and chemotherapy for infants with acute lymphoblastic leukemia; recruitment is ongo…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Validity and Reliability of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity Questionnaire
This clinical trial update describes a planned study to validate the Inflammatory Arthritis Facilitators and Barriers to Physical Activity Q…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL
This clinical trial update describes a study evaluating therapeutic drug monitoring of mercaptopurine to optimize the maintenance phase in c…